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An outbreak of hospital-acquired Acinetobacter baumannii infections, caused by a blaOXA-23-positive carbapenem-resistant
strain belonging to international clone II/ST2, was detected in Latvia. The strain was partially equipped with the armA gene and
the intI1-aacA4-catB8-aadA1-qacE1 class 1 integron. In addition, the strain carried AbaR25, a novel AbaR4-like resistance is-
land of 46,500 bp containing structures similar to the previously described AbaR22 and Tn6167 islands. AbaR25 was character-
ized by the occurrence of a second copy of Tn6022a interrupted by Tn2006 carrying the blaOXA-23 gene.
Acinetobacter baumannii is an aerobic Gram-negative opportu-nistic pathogen with a remarkable ability to acquire resistance
to different classes of antibiotics (1). The increased detection of
multidrug-resistant (MDR) and carbapenem-resistant (CR) A.
baumannii strains in clinical settings is mainly linked to the global
dissemination of a number of highly successful clones, such as
international clones I and II and multilocus sequence types (STs)
15 and ST25 (2).
Resistance to carbapenems in A. baumannii is primarily medi-
ated by the production of carbapenem-hydrolyzing -lactamases
(3). Class B metallo--lactamases (MBLs) confer high levels of
carbapenem resistance as well as resistance to all other -lactams
except for aztreonam, while the substrate profile of class D OXA-
type carbapenemases is commonly diverse, with most of these
enzymes showing a limited hydrolytic activity against imipenem
and meropenem (3). The occurrence of genes encoding aminogly-
coside-modifying enzymes (AME) is the main mechanism of re-
sistance to aminoglycosides in A. baumannii (4). However, strains
producing the 16S rRNA methylase ArmA have also been identi-
fied (5). ArmA has so far been a plasmid-encoded enzyme confer-
ring high levels of resistance to several aminoglycosides (5).
Genomic resistance islands in A. baumannii (AbaR), first de-
tected in 2006, can be sorted into two main models based on their
genetic structures (6, 7). The first model, AbaR3-like, consists of
Tn6019 as a backbone transposon and has, with the exception of
AbaR2, been found only among isolates belonging to interna-
tional clone I (6–10). The second model, AbaR4-like, consists of
Tn6022 as a backbone transposon and has mainly been identified
among isolates from international clone II (11–14). Complex
structures of AbaR4-like islands, such as Tn6167 and AbaR22,
have recently been described (15, 16). Importantly, the AbaR4-
like islands have repeatedly been found to be interrupted by
Tn2006 carrying the blaOXA-23-like gene (12–15).
The aim of this study was to investigate the molecular epide-
miology and antimicrobial resistance characteristics of all the CR
A. baumannii blood culture isolates (n  30) obtained at the P.
Stradins University Hospital (SUH) in Riga, Latvia, between May
2008 and December 2009. The study also included five invasive
(cerebrospinal fluid and blood culture) CR A. baumannii isolates
collected by four hospitals from different cities in Latvia between
March and July 2009 (Table 1).
Resistance to carbapenems was confirmed in all the isolates
(see Table S1 in the supplemental material). Thirty-four isolates
showed high levels of resistance to ciprofloxacin. In addition, high
levels of resistance to amikacin, gentamicin, and tobramycin were
detected in 24 of these isolates. All isolates were susceptible to
colistin. Pulsed-field gel electrophoresis (PFGE), using ApaI-di-
gested genomic DNA, assigned all the 34 ciprofloxacin-resistant
isolates to indistinguishable or closely related patterns, showing
80% similarity to each other (Table 1) (17). Only the ciprofloxa-
cin-susceptible isolate belonged to a possibly related PFGE pattern
showing 70% to 80% similarity to the other patterns. The isolates
belonged to international clone II (n  33) and PCR-based group
4 (n  2), using two multiplex PCRs targeting the ompA, csuE, and
blaOXA-51-like genes (18). Of note, the band pattern of PCR-based
group 4 differs from that of international clone II only in the
negative result for the csuE allele, which could simply be due to a
single polymorphism in the primer annealing regions (19). Mul-
tilocus sequence typing (MLST) was performed on eight isolates
with different PFGE patterns, including the two isolates from
PCR-based group 4 (http://www.pasteur.fr/recherche/genopole
/PF8/mlst/). The isolates were all sorted into ST2 (Table 1).
PCR assays were used to detect antimicrobial resistance genes
encoding the OXA carbapenemases (blaOXA-51-like, blaOXA-23-like,
blaOXA-24-like, and blaOXA-58-like), metallo--lactamases (blaVIM,
blaGIM, blaIMP, and blaSPM), and 16S rRNA methylases (armA,
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rmtA, rmtB, rmtC, rmtD, and npmA) (20). All the isolates were
positive for blaOXA-51-like and blaOXA-23-like, while none of them
carried the blaOXA-24-like, blaOXA-58-like, or metallo--lactamase
genes. The armA gene was detected in all the isolates (n  24)
showing high levels of resistance to amikacin, gentamicin, and
tobramycin (Table 1). Furthermore, sequence analysis detected
the occurrence of the intI1-aacA4-catB8-aadA1-qacE1 class 1 in-
tegron in isolate K51-65. Subsequent PCR assays (see Tables S2 to
S4 in the supplemental material) confirmed the occurrence of this
integron in 20 isolates (Table 1). Interestingly, all the class 1 inte-
gron-positive isolates carried the armA gene, indicating the suc-
ceeding acquisition of armA first and the intI1-aacA4-catB8-
aadA1-qacE1 integron second.
The comM gene was interrupted in all the isolates, indicating
the occurrence of AbaR islands. AbaR25, a novel AbaR4-like is-
land of 46,469 bp, was detected and fully sequenced in isolate K51-65
(Fig. 1; see also Table S2 in the supplemental material). AbaR25 was
most similar to Tn6167 and successively consisted of (i) Tn6022a
(9,148 bp) at the left-hand end; (ii) zone 1 (6,205 bp), including seven
conserved open reading frames of unknown function and a proposed
tyrosine integrase gene; (iii)1Tn6022b (2,892 bp); (iv) zone 2 (9,049
bp), including the ISAba1-sul2-CR2-tetA-tetR-CR2-strB-strA con-
figuration; and (v) 2Tn6022b (2,262 bp), containing orf4b, at the
right-hand end (15). Interestingly, the tetA gene of zone 2 was
interrupted by a sequence of 11,998 bp, representing a complete
second copy of Tn6022a. In addition, the sup gene of this Tn6022a
was interrupted by a sequence of 4,805 bp (Tn2006). Transposi-
tion of Tn6022a/Tn2006 into tetA was associated with the stan-
dard 5-bp target duplication (11). PCR assays (see Tables S3 and
S4 in the supplemental material) confirmed the occurrence of
AbaR25 in 33 isolates and detected the occurrence of AbaR25, a
variant form of AbaR25, in one additional isolate (Table 1).
AbaR25 was fully sequenced in isolate K51-74 and found to be
identical to AbaR25 except for the occurrence of an internal dele-
tion of 5,822 bp (Fig. 1). The deletion included 2,750 bp of
1Tn6022b, ISAba1-sul2-CR2-tetA of zone 2, and 150 bp of
Tn6022a/Tn2006. The deletion was most likely due to a single
intramolecular recombination event between 1Tn6022b and the
corresponding region of Tn6022a/Tn2006. This was indicated by
the occurrence of Tn6022a=/Tn2006, a novel structure character-




(mo/yr) Hospital armA aacA4-catB8-aadA1 AbaR
Clonal
lineage PFGE MLST
K51-65 5/2008 PSCUH   AbaR25 Int. II A1 ST2
K51-66 6/2008 PSCUH   AbaR25 Int. II A2 ST2
K51-67 7/2008 PSCUH   AbaR4 Int. II B ST2
K51-68 9/2008 PSCUH   AbaR25 Group 4 A3 ST2
K51-69 10/2008 PSCUH   AbaR25 Int. II A1 ND
K51-70 10/2008 PSCUH   AbaR25 Int. II A1 ND
K51-71 11/2008 PSCUH   AbaR25 Int. II A1 ND
K51-72 12/2008 PSCUH   AbaR25 Int. II A1 ST2
K51-73 12/2008 PSCUH   AbaR25 Int. II A1 ND
K51-74 1/2009 PSCUH   AbaR25 Int. II A4 ND
K51-75 1/2009 PSCUH   AbaR25 Int. II A1 ND
K51-76 1/2009 PSCUH   AbaR25 Int. II A5 ND
K51-77 1/2009 PSCUH   AbaR25 Int. II A6 ND
K51-78 3/2009 PSCUH   AbaR25 Int. II A7 ND
K51-79 3/2009 PSCUH   AbaR25 Int. II A6 ND
K51-80 3/2009 PSCUH   AbaR25 Int. II A6 ND
K51-81 4/2009 PSCUH   AbaR25 Int. II A1 ND
K70-64 6/2009 PSCUH   AbaR25 Int. II A8 ND
K70-65 6/2009 PSCUH   AbaR25 Int. II A8 ND
K70-66 6/2009 PSCUH   AbaR25 Int. II A9 ND
K70-67 8/2009 PSCUH   AbaR25 Int. II A10 ND
K70-68 9/2009 PSCUH   AbaR25 Int. II A9 ND
K70-69 9/2009 PSCUH   AbaR25 Int. II A9 ND
K70-70 10/2009 PSCUH   AbaR25 Int. II A10 ND
K70-71 10/2009 PSCUH   AbaR25 Int. II A9 ND
K70-72 10/2009 PSCUH   AbaR25 Int. II A9 ND
K70-73 11/2009 PSCUH   AbaR25 Int. II A9 ND
K70-74 12/2009 PSCUH   AbaR25 Int. II A9 ST2
K70-75 12/2009 PSCUH   AbaR25 Int. II A4 ND
K70-76 12/2009 PSCUH   AbaR25 Int. II A9 ND
K70-77 7/2009 DRH   AbaR25 Int. II A2 ND
K70-78 3/2009 VzH   AbaR25 Int. II A1 ND
K70-79 3/2009 VH   AbaR25 Int. II A2 ND
K70-80 6/2009 R1H   AbaR25 Group 4 A3 ST2
K70-81 6/2009 R1H   AbaR25 Int. II A1 ST2
a Abbreviations: PSCUH, P. Stradins Clinical University Hospital, Riga; DRH, Daugavpils Regional Hospital, Daugavpils; VzH, Vidzemes Hospital, Valmiera; VH, Venstpils
Hospital, Ventspils; R1H, Riga 1st Hospital, Riga; Int., international clone; ST, sequence type; ND, not determined.
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ized by a mosaic sequence derived from the two recombined seg-
ments. On the other hand, sequence analysis of the AbaR island in
the ciprofloxacin-susceptible isolate (K51-67) detected an island
of 16,808 bp showing 99.9% similarity with AbaR4 (GenBank ac-
cession numbers JN107991 and CP001182) (7, 12).
Overall, our results detected the occurrence of a strain, repre-
senting 34 out of 35 isolates, responsible for a prolonged ongoing
outbreak/endemic status of hospital-acquired infections in Latvia.
The strain was linked to international clone II/ST2 and carried the
blaOXA-23-like carbapenemase gene within a novel AbaR4-like is-
land. The strain was partially equipped with the armA gene, and
the armA-positive subdivision of this strain has subsequently ac-
quired the aacA4-catB8-aadA1 class 1 integron. The occurrence of
minor differences among the PFGE patterns and limited varia-
tions in the phenotypic and genotypic resistance characteristics
was anticipated since the isolates were collected over a prolonged
period of more than 1 year (17). As previously described, a linkage
was detected between international clone II/ST2 and the armA,
aacA4-catB8-aadA1, and AbaR4-like antimicrobial resistance ele-
ments (2, 14). Further studies are required in order to determine
the evolution and geographical and clonal distribution of the dif-
ferent AbaR islands in A. baumannii.
Nucleotide sequence accession numbers. The nucleotide se-
quences of AbaR25 and AbaR25 were deposited in the GenBank
nucleotide database under accession numbers JX481978 and
JX481979, respectively.
ACKNOWLEDGMENTS
Bjørg Haldorsen and Bettina Aasnæs are acknowledged for excellent tech-
nical assistance. We thank the Genotyping of Pathogens and Public
Health platform (Institut Pasteur) for coding MLST alleles and profiles
available at www.pasteur.fr/recherche/genopole/PF8/mlst.
Part of this project was funded by a research grant from the Northern-
Norway Regional Health Authority, Latvian Research Council, and Na-
tional Research Programme.
REFERENCES
1. Dijkshoorn L, Nemec A, Seifert H. 2007. An increasing threat in hospi-
tals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol.
5:939 –951.
2. Karah N, Sundsfjord A, Towner K, Samuelsen O. 2012. Insights into the
global molecular epidemiology of carbapenem non-susceptible clones of
Acinetobacter baumannii. Drug Resist. Updat. 15:237–247.
3. Poirel L, Nordmann P. 2006. Carbapenem resistance in Acinetobacter
baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12:
826 – 836.
FIG 1 Structures of three different Acinetobacter baumannii resistance islands: Tn6167 (A), AbaR25 (B), and AbaR25 (C) (GenBank accession numbers
JN968483, JX481978, and JX481979, respectively). The genes and open reading frames (orf) are shown by labeled arrows, with the arrowhead indicating the
direction of transcription. The mobile elements ISAba17, ISAba1, and CR2 are shown as labeled open boxes. Inverted repeats are shown as vertical bars. The
vertical dashed arrow in panel A defines the transposition site of the second copy of Tn6022a in AbaR25. The vertical dashed arrows in panel B define the deletion
in AbaR25. The genes and genetic structures are drawn to scale.
Carbapenem-Resistant Acinetobacter baumannii in Latvia
February 2013 Volume 57 Number 2 aac.asm.org 1071
 on M






























4. Nemec A, Dolzani L, Brisse S, van den Broek P, Dijkshoorn L. 2004.
Diversity of aminoglycoside-resistance genes and their association with
class 1 integrons among strains of pan-European Acinetobacter baumannii
clones. J. Med. Microbiol. 53:1233–1240.
5. Cho YJ, Moon DC, Jin JS, Choi CH, Lee YC, Lee JC. 2009. Genetic basis
of resistance to aminoglycosides in Acinetobacter spp. and spread of armA
in Acinetobacter baumannii sequence group 1 in Korean hospitals. Diagn.
Microbiol. Infect. Dis. 64:185–190.
6. Fournier PE, Vallenet D, Barbe V, Audic S, Ogata H, Poirel L, Richet H,
Robert C, Mangenot S, Abergel C, Nordmann P, Weissenbach J, Raoult D,
Claverie JM. 2006. Comparative genomics of multidrug resistance in Acin-
etobacter baumannii. PLoS Genet. 2:e7. doi:10.1371/journal.pgen.0020007.
7. Adams MD, Goglin K, Molyneaux N, Hujer KM, Lavender H, Jamison JJ,
MacDonald IJ, Martin KM, Russo T, Campagnari AA, Hujer AM, Bonomo
RA, Gill SR. 2008. Comparative genome sequence analysis of multidrug-
resistant Acinetobacter baumannii. J. Bacteriol. 190:8053–8064.
8. Iacono M, Villa L, Fortini D, Bordoni R, Imperi F, Bonnal RJ, Sicheritz-
Ponten T, De Bellis G, Visca P, Cassone A, Carattoli A. 2008. Whole-
genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter
baumannii strain belonging to the European clone II group. Antimicrob.
Agents Chemother. 52:2616 –2625.
9. Post V, White PA, Hall RM. 2010. Evolution of AbaR-type genomic
resistance islands in multiply antibiotic-resistant Acinetobacter bauman-
nii. J. Antimicrob. Chemother. 65:1162–1170.
10. Krizova L, Dijkshoorn L, Nemec A. 2011. Diversity and evolution of
AbaR genomic resistance islands in Acinetobacter baumannii strains of
European clone I. Antimicrob. Agents Chemother. 55:3201–3206.
11. Nigro SJ, Hall RM. 2012. Antibiotic resistance islands in A320 (RUH134),
the reference strain for Acinetobacter baumannii global clone 2. J. Antimi-
crob. Chemother. 67:335–338.
12. Hamidian M, Hall RM. 2011. AbaR4 replaces AbaR3 in a carbapenem-
resistant Acinetobacter baumannii isolate belonging to global clone 1 from
an Australian hospital. J. Antimicrob. Chemother. 66:2484 –2491.
13. Hornsey M, Loman N, Wareham DW, Ellington MJ, Pallen MJ, Turton
JF, Underwood A, Gaulton T, Thomas CP, Doumith M, Livermore
DM, Woodford N. 2011. Whole-genome comparison of two Acinetobac-
ter baumannii isolates from a single patient, where resistance developed
during tigecycline therapy. J. Antimicrob. Chemother. 66:1499 –1503.
14. Seputiene V, Povilonis J, Suziedeliene E. 2012. Novel variants of AbaR
resistance islands with a common backbone in Acinetobacter baumannii
isolates of European clone II. Antimicrob. Agents Chemother. 56:1969 –
1973.
15. Nigro SJ, Hall RM. 2012. Tn6167, an antibiotic resistance island in an
Australian carbapenem-resistant Acinetobacter baumannii GC2, ST92 iso-
late. J. Antimicrob. Chemother. 67:1342–1346.
16. Zhou H, Zhang T, Yu D, Pi B, Yang Q, Zhou J, Hu S, Yu Y. 2011.
Genomic analysis of the multidrug-resistant Acinetobacter baumannii
strain MDR-ZJ06 widely spread in China. Antimicrob. Agents Che-
mother. 55:4506 – 4512.
17. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE,
Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA
restriction patterns produced by pulsed-field gel electrophoresis: criteria
for bacterial strain typing. J. Clin. Microbiol. 33:2233–2239.
18. Turton JF, Gabriel SN, Valderrey C, Kaufmann ME, Pitt TL. 2007. Use
of sequence-based typing and multiplex PCR to identify clonal lineages of
outbreak strains of Acinetobacter baumannii. Clin. Microbiol. Infect. 13:
807– 815.
19. Towner KJ, Levi K, Vlassiadi M. 2008. Genetic diversity of carbapenem-
resistant isolates of Acinetobacter baumannii in Europe. Clin. Microbiol.
Infect. 14:161–167.
20. Karah N, Haldorsen B, Hermansen NO, Tveten Y, Ragnhildstveit E,
Skutlaberg DH, Tofteland S, Sundsfjord A, Samuelsen O. 2011. Emer-
gence of OXA-carbapenemase- and 16S rRNA methylase-producing in-
ternational clones of Acinetobacter baumannii in Norway. J. Med. Micro-
biol. 60:515–521.
Saule et al.
1072 aac.asm.org Antimicrobial Agents and Chemotherapy
 on M
arch 17, 2014 by U
N
IV
E
R
S
IT
E
T
S
B
IB
LIO
T
E
K
E
T
 I T
R
O
M
S
O
http://aac.asm
.org/
D
ow
nloaded from
 
